BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15748161)

  • 1. PKC site mutations reveal differential modulation by insulin of NMDA receptors containing NR2A or NR2B subunits.
    Jones ML; Leonard JP
    J Neurochem; 2005 Mar; 92(6):1431-8. PubMed ID: 15748161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI 3-kinase and PKCζ mediate insulin-induced potentiation of NMDA receptor currents in Xenopus oocytes.
    Jones ML; Liao GY; Malecki R; Li M; Salazar NM; Leonard JP
    Brain Res; 2012 Jan; 1432():7-14. PubMed ID: 22137655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The postsynaptic density protein PSD-95 differentially regulates insulin- and Src-mediated current modulation of mouse NMDA receptors expressed in Xenopus oocytes.
    Liao GY; Kreitzer MA; Sweetman BJ; Leonard JP
    J Neurochem; 2000 Jul; 75(1):282-7. PubMed ID: 10854272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced NMDA receptor tyrosine phosphorylation in PTPalpha-deficient mouse synaptosomes is accompanied by inhibition of four src family kinases and Pyk2: an upstream role for PTPalpha in NMDA receptor regulation.
    Le HT; Maksumova L; Wang J; Pallen CJ
    J Neurochem; 2006 Sep; 98(6):1798-809. PubMed ID: 16899073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C enhances glycine-insensitive desensitization of NMDA receptors independently of previously identified protein kinase C sites.
    Jackson MF; Konarski JZ; Weerapura M; Czerwinski W; MacDonald JF
    J Neurochem; 2006 Mar; 96(6):1509-18. PubMed ID: 16417568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-D-aspartate receptors in nascent neocortical synapses.
    Mohrmann R; Köhr G; Hatt H; Sprengel R; Gottmann K
    J Neurosci Res; 2002 May; 68(3):265-75. PubMed ID: 12111856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient forebrain ischemia effects interaction of Src, FAK, and PYK2 with the NR2B subunit of N-methyl-D-aspartate receptor in gerbil hippocampus.
    Zalewska T; Ziemka-Nałecz M; Domańska-Janik K
    Brain Res; 2005 May; 1042(2):214-23. PubMed ID: 15854593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical role of the N-methyl-D-aspartate (NMDA) receptor subunit (NR) 2A in the expression of redox sensitivity of NR1/NR2A recombinant NMDA receptors.
    Brimecombe JC; Potthoff WK; Aizenman E
    J Pharmacol Exp Ther; 1999 Nov; 291(2):785-92. PubMed ID: 10525101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia.
    Ma J; Zhang GY; Liu Y; Yan JZ; Hao ZB
    Neurosci Res; 2004 Aug; 49(4):357-62. PubMed ID: 15236860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins.
    Iwamoto T; Yamada Y; Hori K; Watanabe Y; Sobue K; Inui M
    J Neurochem; 2004 Apr; 89(1):100-8. PubMed ID: 15030393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase potentiates NMDA receptor currents by reducing tonic zinc inhibition.
    Zheng F; Gingrich MB; Traynelis SF; Conn PJ
    Nat Neurosci; 1998 Jul; 1(3):185-91. PubMed ID: 10195142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C activation induces tyrosine phosphorylation of the NR2A and NR2B subunits of the NMDA receptor.
    Grosshans DR; Browning MD
    J Neurochem; 2001 Feb; 76(3):737-44. PubMed ID: 11158244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src-protein tyrosine kinases are required for cocaine-induced increase in the expression and function of the NMDA receptor in the ventral tegmental area.
    Schumann J; Michaeli A; Yaka R
    J Neurochem; 2009 Feb; 108(3):697-706. PubMed ID: 19046409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
    Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ
    Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.
    Dunah AW; Wang Y; Yasuda RP; Kameyama K; Huganir RL; Wolfe BB; Standaert DG
    Mol Pharmacol; 2000 Feb; 57(2):342-52. PubMed ID: 10648644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
    Schotanus SM; Chergui K
    Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons.
    Thomas CG; Miller AJ; Westbrook GL
    J Neurophysiol; 2006 Mar; 95(3):1727-34. PubMed ID: 16319212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
    Christie JM; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.